HK-listed Jinxin Fertility Group jumps on expansion deals

Reuters2021-06-21

** Shares of China's assisted reproductive services provider Jinxin Fertility Group Ltd rise as much as 13.6% to HK$20.90, their biggest intraday percentage gain since May 31

** Stock, the eighth biggest percentage gainer on the Hong Kong bourse, hits its highest since June 4

** The Sichuan-based company says its unit has agreed to buy a 10% stake in Guangdong Kangzhi Hospital Management Co Ltd from Honz Pharmaceutical Co Ltd for 37.7 mln yuan ($5.8 mln)

** Says its 15%-owned Tianjin Binhai Yuanxian Management Consulting Center will buy from Honz and certain independent third parties 90% of Guangdong Kangzhi Hospital, and stakes in Yunnan Jiuzhou Hospital and Kunming Hewanjia Obstetrics and Gynecology Hospital

** Says the acquisitions will expand productivity and capacity of its network in mainland China

** Shenzhen shares of Honz rise 1.4%

** The Hong Kong Hang Seng Commerce & Industry Index slips 0.4%, while the healthcare index rises 1.7%

** The Hang Seng China enterprises index slides 0.8% and the benchmark index drops 1.1%

** As of last close, the stock had surged 16.5% this year

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
30